title: Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa.
abstract: Pseudomonas aeruginosa is an opportunistic human pathogen and one of the leading causes of nosocomial infections worldwide. The difficulty in treatment of pseudomonas infections arises from being multidrug resistant (MDR) and exhibits resistance to most antimicrobial agents due to the expression of different mechanisms overcoming their effects. Of these resistance mechanisms, the active efflux pumps in Pseudomonas aeruginosa that belong to the resistance nodulation division (RND) plays a very important role in extruding the antibiotics outside the bacterial cells providing a protective means against their antibacterial activity. Beside its role against the antimicrobial agents, these pumps can extrude biocides, detergents, and other metabolic inhibitors. It is clear that efflux pumps can be targets for new antimicrobial agents. Peptidomimetic compounds such as phenylalanine arginyl β-naphthylamide (PAβN) have been introduced as efflux pump inhibitors (EPIs); their mechanism of action is through competitive inhibition with antibiotics on the efflux pump resulting in increased intracellular concentration of antibiotic, hence, restoring its antibacterial activity. The advantage of EPIs is the difficulty to develop bacterial resistance against them, but the disadvantage is their toxic property hindering their clinical application. The structure activity relationship of these compounds showed other derivatives from PAβN that are higher in their activity with higher solubility in biological fluids and decreased toxicity level. This raises further questions on how can we compact Pseudomonas infections. Of particular importance, the recent resurgence in the use of older antibiotics such as polymyxins and probably applying stricter control measures in order to prevent their spread in clinical sittings.
authors: Biochemistry, Immunology and Microbiology (BMI) Department, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
authors: Momen
authors: M
authors: Askoura
authors: Walid
authors: W
authors: Mottawea
authors: Turki
authors: T
authors: Abujamel
authors: Ibrahim
authors: I
authors: Taher
references: Clin Infect Dis. 1993 Mar;16(3):372-6
references: 8452949
references: J Bacteriol. 2002 Sep;184(18):5036-44
references: 12193619
references: Bioorg Med Chem Lett. 2003 Dec 1;13(23):4241-4
references: 14623009
references: J Bacteriol. 2002 Aug;184(15):4308-12
references: 12107151
references: Microbiology (Reading). 2002 Aug;148(Pt 8):2371-2381
references: 12177331
references: Curr Microbiol. 2009 Sep;59(3):352-5
references: 19554368
references: Antimicrob Agents Chemother. 2001 Jan;45(1):105-16
references: 11120952
references: Antimicrob Agents Chemother. 2000 Mar;44(3):710-2
references: 10681343
references: Bioorg Med Chem. 2006 Dec 15;14(24):8506-18
references: 16979895
references: Trends Microbiol. 2001 Jan;9(1):34-9
references: 11166241
references: Bioorg Med Chem. 2006 Mar 15;14(6):1993-2004
references: 16290941
references: Clin Microbiol Rev. 2006 Apr;19(2):382-402
references: 16614254
references: Clin Microbiol Infect. 2006 Apr;12(4):315-21
references: 16524407
references: J Mol Microbiol Biotechnol. 2001 Apr;3(2):255-64
references: 11321581
references: Genet Mol Res. 2003 Mar 31;2(1):48-62
references: 12917802
references: J Microbiol Methods. 2009 Nov;79(2):232-7
references: 19799939
references: Antimicrob Agents Chemother. 2009 Aug;53(8):3430-6
references: 19433570
references: FEMS Microbiol Rev. 2009 Mar;33(2):279-94
references: 19243444
references: Int J Antimicrob Agents. 2007 Jun;29(6):630-6
references: 17306965
references: Lancet Infect Dis. 2006 Sep;6(9):589-601
references: 16931410
references: Biochim Biophys Acta. 2009 May;1794(5):817-25
references: 19289182
references: Int J Antimicrob Agents. 2006 Jun;27(6):565-9
references: 16707249
references: Microbiol Immunol. 2005;49(11):999-1002
references: 16301811
references: FEMS Microbiol Lett. 2009 Oct;299(2):200-4
references: 19709308
references: Antimicrob Agents Chemother. 2000 Dec;44(12):3322-7
references: 11083635
references: Antimicrob Agents Chemother. 2008 Nov;52(11):4141-4
references: 18676884
references: J Antimicrob Chemother. 2003 Dec;52(6):987-92
references: 14585859
references: Int J Antimicrob Agents. 2009 Oct;34(4):343-6
references: 19615866
references: Bioorg Med Chem Lett. 2002 Mar 11;12(5):763-6
references: 11858997
references: Appl Environ Microbiol. 2008 Mar;74(6):1932-5
references: 18192403
references: Curr Drug Targets. 2006 Jul;7(7):843-7
references: 16842215
references: J Med Microbiol. 2009 Sep;58(Pt 9):1133-1148
references: 19528173
references: Antimicrob Agents Chemother. 2008 Jul;52(7):2455-62
references: 18474583
references: Clin Infect Dis. 2005 May 1;40(9):1333-41
references: 15825037
references: Curr Opin Pharmacol. 2009 Oct;9(5):558-65
references: 19748829
references: Nature. 2006 Sep 14;443(7108):173-9
references: 16915237
references: Int J Antimicrob Agents. 2009 Feb;33(2):174-6
references: 18945595
references: Biochim Biophys Acta. 2009 May;1794(5):826-33
references: 19150515
references: Drug Resist Updat. 2000 Aug;3(4):247-255
references: 11498392
references: Clin Infect Dis. 2002 Mar 1;34(5):634-40
references: 11823954
references: Am J Infect Control. 2006 Jun;34(5 Suppl 1):S29-37; discussion S64-73
references: 16813979
references: Infect Control Hosp Epidemiol. 2000 Feb;21(2):80-5
references: 10697282
references: Antimicrob Agents Chemother. 2005 Feb;49(2):565-70
references: 15673734
references: J Bacteriol. 2008 Jul;190(13):4447-52
references: 18469108
references: Int J Antimicrob Agents. 2009 Nov;34(5):414-8
references: 19656662
references: J Bacteriol. 1947 Jul;54(1):24
references: 20344246
references: Burns. 2009 Nov;35(7):1020-5
references: 19501980
references: Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13586-91
references: 18757728
references: Int J Antimicrob Agents. 2004 Dec;24(6):529-35
references: 15555873
references: Bioorg Med Chem Lett. 2003 Aug 18;13(16):2755-8
references: 12873508
references: Biochem Pharmacol. 2006 Mar 30;71(7):910-8
references: 16427026
references: Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):9994-9
references: 15226509
references: Infect Immun. 2009 Oct;77(10):4559-66
references: 19651866
references: J Antimicrob Chemother. 2007 Jun;59(6):1223-9
references: 17229832
references: J Biol Chem. 2003 Jan 24;278(4):2085-8
references: 12460990
references: Nat Rev Drug Discov. 2007 Jan;6(1):56-65
references: 17159924
references: Bioorg Med Chem. 2007 Nov 15;15(22):7087-97
references: 17869116